IE40681B1 - Oral pharmaceutical preparation - Google Patents

Oral pharmaceutical preparation

Info

Publication number
IE40681B1
IE40681B1 IE363/75A IE36375A IE40681B1 IE 40681 B1 IE40681 B1 IE 40681B1 IE 363/75 A IE363/75 A IE 363/75A IE 36375 A IE36375 A IE 36375A IE 40681 B1 IE40681 B1 IE 40681B1
Authority
IE
Ireland
Prior art keywords
oral pharmaceutical
pharmaceutical preparation
carbon atoms
steroid
preparation
Prior art date
Application number
IE363/75A
Other languages
English (en)
Other versions
IE40681L (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IE40681L publication Critical patent/IE40681L/xx
Publication of IE40681B1 publication Critical patent/IE40681B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IE363/75A 1974-02-28 1975-02-21 Oral pharmaceutical preparation IE40681B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7402689,A NL189235C (nl) 1974-02-28 1974-02-28 Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Publications (2)

Publication Number Publication Date
IE40681L IE40681L (en) 1975-08-28
IE40681B1 true IE40681B1 (en) 1979-08-01

Family

ID=19820854

Family Applications (1)

Application Number Title Priority Date Filing Date
IE363/75A IE40681B1 (en) 1974-02-28 1975-02-21 Oral pharmaceutical preparation

Country Status (11)

Country Link
US (1) US4220599A (enExample)
BE (1) BE826086A (enExample)
CA (1) CA1038760A (enExample)
DE (1) DE2508615A1 (enExample)
FR (1) FR2262527B1 (enExample)
GB (1) GB1500374A (enExample)
HU (1) HU173417B (enExample)
IE (1) IE40681B1 (enExample)
NL (1) NL189235C (enExample)
PH (1) PH13807A (enExample)
ZA (1) ZA751007B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7506407A (nl) * 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
GB1567515A (en) * 1976-05-28 1980-05-14 Akzo Nv Esters of testo-sterone and 5 -dihydro-testosterone
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
CZ20013912A3 (cs) * 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
MXPA03001147A (es) * 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
US20050287203A1 (en) * 2002-05-08 2005-12-29 Nijs De H Formulation comprising testosteron undecanoate and castor oil
WO2006113505A2 (en) 2005-04-15 2006-10-26 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) * 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
EP3157505B1 (en) 2014-06-17 2019-07-24 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2855341A (en) * 1954-07-02 1958-10-07 Ciba Pharm Prod Inc Testosterone compositions
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3374230A (en) * 1966-04-26 1968-03-19 Schering Corp Acetylation of steroidal alcohols with ketene
CH499507A (de) * 1966-12-09 1970-11-30 Ciba Geigy Ag Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation

Also Published As

Publication number Publication date
NL189235C (nl) 1993-02-16
HU173417B (hu) 1979-05-28
FR2262527A1 (enExample) 1975-09-26
FR2262527B1 (enExample) 1978-08-04
AU7838675A (en) 1976-08-26
PH13807A (en) 1980-10-01
IE40681L (en) 1975-08-28
DE2508615C2 (enExample) 1989-10-12
DE2508615A1 (de) 1975-09-04
GB1500374A (en) 1978-02-08
ZA751007B (en) 1976-01-28
BE826086A (fr) 1975-08-27
US4220599A (en) 1980-09-02
NL189235B (nl) 1992-09-16
CA1038760A (en) 1978-09-19
NL7402689A (nl) 1975-09-01

Similar Documents

Publication Publication Date Title
IE40681L (en) Oral pharmaceutical preparation
IE42692L (en) Oestrogenic compositions
IE44533L (en) ORAL PREPARATION CONTAINING A 17ß-ESTER OF NANDROLONE
IE44562L (en) Pharmaceutical compositions of addicting agents having¹reduced addiction liability
IE45390L (en) Anti-caries composition
CA2069483A1 (en) Steroid sulphatase inhibitors
JPS5294433A (en) Perfume blender
HU171632B (hu) Sposob umen'shenija neprijatnogo zapakha i preduprezhdenija razlozhenija v techenii khranenija akaricidov s s,s-dialkil'nymi-0-alkil'nymi slozhnymi ehfirami /s1-4 uglerodnymi atomami/ ditiofosfornoj kisloty v kachestve aktivnogo vehhestva
IE790821L (en) Steroid-containing composition
NL7704105A (nl) Werkwijze voor de bereiding van steroidecar- bonzuren en de esters daarvan.
NL7706799A (nl) Werkwijze ter bereiding van een geneesmiddel, werkwijze ter bereiding van de indoolazijnzure ester als actieve component en het gevormde geneesmiddel.
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
CA1034578A (en) 2,5-di-substituted 4-oxazoleakanoic acids and esters
NL7614023A (nl) Depot-steroide-esters, werkwijze voor het be- reiden daarvan, alsmede werkwijze voor het be- reiden van een daarop gebaseerd geneesmiddel met oestrogene, resp. gestagene werking.
ZA744750B (en) 16-methyl-pregna-1,4,9 (11)-triene-3,20-diones as medicaments- new processes for the preparation of these products, and pharmaceutical compositions
GB1273025A (en) 07alpha-(2',3'-BUTADIEN-2'-YL)-ESTR-4-EN-17beta-OL-3-ONE
IL45142A0 (en) Process for the preparation of 17-acyl esters of 17alpha,21-dihydroxysteroids of the pregnane series and new products obtained
IE45709L (en) DIBENZ [b,f] AZEPINE DERIVATIVE.
GB1164705A (en) Preparation of Delta<7>-Dehydro Steroids
CA994044A (fr) Copolymeres d'acetate de vinyle, d'ester maleique et d'acide crotonique
CA793307A (en) 16-OXYGENATED-20-METHYL-.DELTA.17(20) PREGNEN-21-OIC ACIDS, 16-OXYGENATED-17.alpha.,20.alpha.-METHYLENE-21-OIC ACIDS OF THE PREGNANE SERIES, THEIR ESTERS, AND PROCESS FOR THEIR PREPARATION
HU171992B (hu) Insekticidnye, akaricidnye i nematocidnye kompozicija soderzhahhie slozhnye efiry i efiramidy 0-triazolil-skobka-tiono-skobka zakryta-fosfornojj-, skobka-fosfonnojj-ili fosfinnojj-skobka zakryta-kislot, i sposob poluchenija aktivnykh agentov
IE42283L (en) 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones
CA733497A (en) PROCESS FOR THE PRODUCTION OF 17.alpha.-ALKYNYLANDROSTA-4,6-DIENE-3,17-DIOLS, ESTERS THEREOF AND CORRESPONDING 19-NOR COMPOUNDS
GB1318662A (en) Stable compositions of epithio-steroids